万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生2>>药学
您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>精神病学

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY《国际临床精神药理学》 (官网投稿)

简介
  • 期刊简称INT CLIN PSYCHOPHARM
  • 参考译名《国际临床精神药理学》
  • 核心类别 SCIE(2023版), 外文期刊,
  • IF影响因子
  • 自引率8.20%
  • 主要研究方向医学-PHARMACOLOGY & PHARMACY 药学;PSYCHIATRY 精神病学

主要研究方向:

等待设置主要研究方向
医学-PHARMACOLOGY & PHARMACY 药学;PSYCHIATRY 精神病学

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY《国际临床精神药理学》(双月刊). ​​​International Clinical Psychopharmacology provides an essential link between research and cli...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿

2期刊网址:

https://journals.lww.com/intclinpsychopharm/pages/default.aspx

3投稿网址:https://www.editorialmanager.com/icp/

4、官网邮箱:ICP@samontgomery.co.uk(主编)

5、期刊刊期:双月刊,一年出版6期。

2021年8月20日星期

                                 

 

投稿须知【官网信息】

 

International Clinical Psychopharmacology

Guidance for Authors

Guidance for authors on the preparation and submission of manuscripts to International Clinical Psychopharmacology

Note: These instructions comply with those formulated by the International Committee of Medical Journal Editors. For further details, authors should consult the "Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals" at www.icmje.org.

The Journal is a member of the Committee on Publication Ethics (COPE) which aims to define best practice in the ethics of scientific publishing. COPE has established a number of guidelines as part of a set of Core Practices (www.publicationethics.org).

Appeals on editorial decisions should be sent to the Editor. Complaints related to how your paper was processed during peer-review and not resolved by the Editor, should be referred to the person named as publisher in "About the Journal" under "Journal Info" contacts (http://journals.lww.com/intclinpsychopharm/Pages/aboutthejournal.aspx), or if unsatisfied to COPE (www.publicationethics.org).

This Journal allows authors to choose an Open Access option for their published article on payment of a fee. See the Open Access section below.

SCOPE

International Clinical Psychopharmacology is a peer-reviewed journal of psychopharmacology directed to an audience of research scientists, physicians and other health care workers. The Journal publishes reports on studies in human subjects that relate to effects of drugs on psychological processes, pharmacological therapy for mental health conditions and practical clinical issues related to drug therapy. Publication of original research reports, short reports, reviews and case reports will be considered.

Submitted articles undergo a preliminary review by the editor. Some articles may be returned to authors without further consideration. Those being considered for publication will undergo further assessment and peer-review by the editor and those invited to do so from the board and reviewer pool.

SUBMISSIONS

Original scientific papers must be submitted through the web-based submission and tracking system, Editorial Manager, at http://www.editorialmanager.com/icp/. The site contains detailed instructions and advice on how to use the system. You should NOT in addition mail a hard-copy submission to the editorial office, unless you have been instructed to do so by the editorial office.

Double spacing should be used throughout the manuscript, which should include the following sections, each starting on a separate page: title page, abstract and keywords, text, acknowledgements, references, individual tables and captions. Margins should be not less than 3 cm. Pages should be numbered consecutively, beginning with the title page, and the page number should be placed in the top right-hand corner of each page. Abbreviations should be defined on their first appearance in the text; those not accepted by international bodies should be avoided.

Non-native speakers of English: Authors who are not native speakers of English and require help in writing an article in English are encouraged to seek assistance from a qualified colleague or consider using a language service in preparing a manuscript submission. Wolters Kluwer, in partnership with Editage, offers such services - for more information please visit http://wkauthorservices.editage.com. Please note that the use of this or other services are at the author's own expense and risk, and independent from the editorial processes of this journal, and does not guarantee that an article will be accepted for publication.

Article Types

Original Article

Manuscripts should be concise and not more than 3500 words, with up to five figures or tables.  The word limit refers to the main body of the text and does not include the abstract, references or figure legends.  A limited number of supplementary data tables and/or figures which enhance the publication may be submitted for consideration for online posting.

Review

These must be evidence based state of the art reviews or meta-analyses.

Case Report

Case reports will only be considered if they are sufficiently original and important.

POINTS TO CONSIDER WHEN SUBMITTING YOUR PAPER TO ONE OF OUR JOURNALS

Please think carefully about the following points and make the appropriate declarations.

……

更多详情:

https://edmgr.ovid.com/icp/accounts/ifauth.htm


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭